BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2854 related articles for article (PubMed ID: 25970248)

  • 1. Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.
    Spranger S; Bao R; Gajewski TF
    Nature; 2015 Jul; 523(7559):231-5. PubMed ID: 25970248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic β-catenin signaling suppresses CD8
    Xue J; Yu X; Xue L; Ge X; Zhao W; Peng W
    Biomed Pharmacother; 2019 Jul; 115():108921. PubMed ID: 31078045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excluding T Cells: Is β-Catenin the Full Story?
    Hu-Lieskovan S; Homet Moreno B; Ribas A
    Cancer Cell; 2015 Jun; 27(6):749-50. PubMed ID: 26058073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment.
    Li X; Xiang Y; Li F; Yin C; Li B; Ke X
    Front Immunol; 2019; 10():2293. PubMed ID: 31616443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma.
    Trujillo JA; Luke JJ; Zha Y; Segal JP; Ritterhouse LL; Spranger S; Matijevich K; Gajewski TF
    J Immunother Cancer; 2019 Nov; 7(1):295. PubMed ID: 31703593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients.
    Massi D; Romano E; Rulli E; Merelli B; Nassini R; De Logu F; Bieche I; Baroni G; Cattaneo L; Xue G; Mandalà M
    Eur J Cancer; 2017 Jun; 78():70-81. PubMed ID: 28412591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment.
    Gajewski TF; Corrales L; Williams J; Horton B; Sivan A; Spranger S
    Adv Exp Med Biol; 2017; 1036():19-31. PubMed ID: 29275462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment.
    Tsukamoto H; Fujieda K; Miyashita A; Fukushima S; Ikeda T; Kubo Y; Senju S; Ihn H; Nishimura Y; Oshiumi H
    Cancer Res; 2018 Sep; 78(17):5011-5022. PubMed ID: 29967259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The density and spatial tissue distribution of CD8
    Massi D; Rulli E; Cossa M; Valeri B; Rodolfo M; Merelli B; De Logu F; Nassini R; Del Vecchio M; Di Guardo L; De Penni R; Guida M; Sileni VC; Di Giacomo AM; Tucci M; Occelli M; Portelli F; Vallacchi V; Consoli F; Quaglino P; Queirolo P; Baroni G; Carnevale-Schianca F; Cattaneo L; Minisini A; Palmieri G; Rivoltini L; Mandalà M;
    J Immunother Cancer; 2019 Nov; 7(1):308. PubMed ID: 31730502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZEB1 transcription factor promotes immune escape in melanoma.
    Plaschka M; Benboubker V; Grimont M; Berthet J; Tonon L; Lopez J; Le-Bouar M; Balme B; Tondeur G; de la Fouchardière A; Larue L; Puisieux A; Grinberg-Bleyer Y; Bendriss-Vermare N; Dubois B; Caux C; Dalle S; Caramel J
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
    Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
    J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of β-Catenin-Induced CCL28 Suppresses Gastric Cancer Progression via Inhibition of Treg Cell Infiltration.
    Ji L; Qian W; Gui L; Ji Z; Yin P; Lin GN; Wang Y; Ma B; Gao WQ
    Cancer Res; 2020 May; 80(10):2004-2016. PubMed ID: 32156780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers.
    Luke JJ; Bao R; Sweis RF; Spranger S; Gajewski TF
    Clin Cancer Res; 2019 May; 25(10):3074-3083. PubMed ID: 30635339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell programming in pancreatic adenocarcinoma: a review.
    Seo YD; Pillarisetty VG
    Cancer Gene Ther; 2017 Mar; 24(3):106-113. PubMed ID: 27910859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapy.
    Gattinoni L; Ji Y; Restifo NP
    Clin Cancer Res; 2010 Oct; 16(19):4695-701. PubMed ID: 20688898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.
    Twyman-Saint Victor C; Rech AJ; Maity A; Rengan R; Pauken KE; Stelekati E; Benci JL; Xu B; Dada H; Odorizzi PM; Herati RS; Mansfield KD; Patsch D; Amaravadi RK; Schuchter LM; Ishwaran H; Mick R; Pryma DA; Xu X; Feldman MD; Gangadhar TC; Hahn SM; Wherry EJ; Vonderheide RH; Minn AJ
    Nature; 2015 Apr; 520(7547):373-7. PubMed ID: 25754329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 18. B7-H3 drives immunosuppression and Co-targeting with CD47 is a new therapeutic strategy in β-catenin activated melanomas.
    Hsu M; Martin TC; Vyas NS; Desman G; Mendelson K; Horst B; Parsons RE; Celebi JT
    Pigment Cell Melanoma Res; 2023 Sep; 36(5):407-415. PubMed ID: 37086018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.
    Figueiredo CR; Kalirai H; Sacco JJ; Azevedo RA; Duckworth A; Slupsky JR; Coulson JM; Coupland SE
    J Pathol; 2020 Apr; 250(4):420-439. PubMed ID: 31960425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
    Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 143.